lan calls for an estimated 300-400 essential medicines to be made available at all public facilities, starting at the grassroots level. In October 2009, the NDRC reduced the prices of 2,349 drugs by an average 12%. These drugs represent around 45% of drugs on the Essential Medicines System. The prices of 49% of drugs on the list will not be reduced while the remaining 6% that are in short supply will see their prices increased moderately in order to encourage their manufacture.
DETAILED REPORT CONTENTS
COUNTRY ANALYSIS
Key National Indicators
Economic, population, and health data forecast to 2014
Healthcare system
Organisation & administration
Health expenditure
Expenditure by source of funding and type
Hospital services
Hospital data such as beds by type, region, specialty, patient admissions and surgical procedures
Outpatient care
Medical personnel
Data on healthcare professionals covering such areas as doctors by specialty, nursing staff and dentists
...
Accessing the pharmaceutical market
Regulatory environment
Distribution guide and trade fair information
Domestic production
Contact details
For healthcare organisations and trade associations
QUARTERLY-UPDATED REPORTS INCLUDED!
Buyers of this report will receive, for each market, 4 quarterly reports covering:
Current market size
Unique 5-year market projections to 2014
Market outlook & structure
Comment & rating
Import and export data
Market developments, covering recent and impending developments with respect to key issues such as regulation, health facilities, and funding
To order this report:Pharmaceutical Industry:
SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine technology :1.
Reportlinker Adds US Disposable Medical Supplies Market Report2.
Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile3.
Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech4.
Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery5.
Reportlinker Adds Reinventing Pharmaceutical Sales Forces6.
Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 20147.
Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery8.
Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 20159.
Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities10.
Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis11.
Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)